These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6484894)

  • 1. Synthesis of an affinity chromatography gel for AT III. Effect of purification of AT III-binding sequence of heparin.
    Tomono T; Igarashi S; Sawada E
    Thromb Res; 1984 Aug; 35(4):467-73. PubMed ID: 6484894
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW; Berry LR; Kaur H; Koj A; Regoeczi E
    Can J Biochem; 1979 Oct; 57(10):1183-90. PubMed ID: 120212
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW; Eggleton CA; Mahmoud M
    Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of quantitative affinity chromatography for characterizing high-affinity interactions: binding of heparin to antithrombin III.
    Hogg PJ; Jackson CM; Winzor DJ
    Anal Biochem; 1991 Feb; 192(2):303-11. PubMed ID: 2035830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).
    De Stefano V; Leone G; Ferrelli R; Di Donfrancesco A; De Martini D; Bizzi B
    Thromb Res; 1987 Oct; 48(1):23-30. PubMed ID: 3424283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
    Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract]   [Full Text] [Related]  

  • 9. Capillary affinity chromatography and affinity capillary electrophoresis of heparin binding proteins.
    Wu X; Linhardt RJ
    Electrophoresis; 1998 Nov; 19(15):2650-3. PubMed ID: 9848674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin binding and protease inhibitor activity of chemically modified antithrombin III.
    Blackburn MN; Smith RL; Sibley CC; Johnson VA
    Ann N Y Acad Sci; 1981; 370():700-7. PubMed ID: 6791550
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor.
    Danishefsky I; Tzeng F; Ahrens M; Klein S
    Thromb Res; 1976 Feb; 8(2):131-40. PubMed ID: 56053
    [No Abstract]   [Full Text] [Related]  

  • 17. Affinity high-performance liquid chromatography on heparin-Glc-Spheron.
    Dyr JE; Suttnar J
    J Chromatogr; 1991 Jan; 563(1):124-8. PubMed ID: 2061378
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III.
    Zhao R; Luo J; Shangguan D; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):175-81. PubMed ID: 15664348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.